Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Recombinant Human Angiotensin-Converting Enzyme 2[2] Alunacedase alfa (Recombinant Human Angiotensin-Converting Enzyme 2),
Angiotensin II		[2] Angiotensin II ,
Angiotensin II 💬 		[2] AGTR1,
AGTR2 💬 		[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
2Recombinant Human Angiotensin-converting enzyme 2 (ACE2), APN01[2] Alunacedase alfa (Recombinant Human Angiotensin-Converting Enzyme 2),
Angiotensin II		[2] Angiotensin II ,
Angiotensin II 💬 		[2] AGTR1,
AGTR2 💬 		[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬